Registered Number: SC492045 Scotland ## FIBROMYALGIA ACTION UK Report of the Directors and Unaudited Financial Statements ## **Period of accounts** **Start date:** 01 December 2021 **End date:** 30 November 2022 FIBROMYALGIA ACTION UK Contents Page For the year ended 30 November 2022 |Company information|3| |---|---| |Directors' report|4| |Accountants' report|6| |Income statement|7| |Statement of financial position|8| |Notes to the financial statements|10| |Detailed income statement|14| 2 of 15 FIBROMYALGIA ACTION UK Company Information For the year ended 30 November 2022 **Directors** Glen McGregor Janet Horton Des Quinn Helen Margaret Watts **Registered Number** SC492045 **Registered Office** 12 Seedhill Road 3007 Mile End Mill Paisley PA1 1JS **Accountants** Josh Botham Tax & Accounting Services Ltd Archer House Britland Estate Northbourne Road Eastbourne BN22 8PW 3 of 15 FIBROMYALGIA ACTION UK Directors' Report For the year ended 30 November 2022 ## **Director's report and financial statements** The directors present his/her/their annual report and the financial statements for the year ended 30 November 2022. ## **Principal activities** Principal activity of the company during the financial year was of Fibromyalgia awareness. ## **Statement of directors' responsibilities** The directors are responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice. Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (Financial Reporting Standard 102). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period. In preparing these financial statements, the directors are required to : - select suitable accounting policies and then apply them consistently - make judgements and accounting estimates that are reasonable and prudent state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and - prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The directors are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions ## **Directors** The directors who served the company throughout the year were as follows: Glen McGregor Janet Horton Des Quinn Helen Margaret Watts 4 of 15 ## FIBROMYALGIA ACTION UK Directors' Report For the year ended 30 November 2022 This report was approved by the board and signed on its behalf by: ---------------------------------- Glen McGregor Director Date approved: 26 January 2023 5 of 15 ## FIBROMYALGIA ACTION UK Accountants' Report For the year ended 30 November 2022 Accountant’s report You consider that the company is exempt from an audit for the year ended 30 November 2022 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. Josh Botham Tax & Accounting Services Ltd 30 November 2022 .................................................... Josh Botham Tax & Accounting Services Ltd Archer House Britland Estate Northbourne Road Eastbourne BN22 8PW 26 January 2023 6 of 15 ## FIBROMYALGIA ACTION UK Income Statement For the year ended 30 November 2022 |**Notes**
**Turnover**
Cost of sales
**Gross profit**
Selling and distribution costs
Administrative expenses
**Operating profit**
2
Interest payable and similar charges
4
**Profit/(Loss) on ordinary activities before taxation**
Tax on profit on ordinary activities
**Profit/(Loss) for the financial year**|**2022**
**£**
103,240
(48,566)
**54,674**
(3,577)
(44,038)
**7,059**
0
**7,059**
0
**7,059**|**2021**
**£**
155,074
(43,399)| |---|---|---| |||**111,675**
(3,773)
(79,889)| |||**28,013**
(16)| |||**27,997**
0| |||**27,997**| 7 of 15 ## FIBROMYALGIA ACTION UK Statement of Financial Position As at 30 November 2022 |**Notes**
**Fixed assets**
Tangible fixed assets
5
**Current assets**
Stocks
6
Debtors: amounts falling due within one year
7
Cash at bank and in hand
**Creditors: amount falling due within one year**
8
**Net current assets**
**Total assets less current liabilities**
**Net assets**
**Capital and reserves**
Profit and loss account
9
**Shareholder's funds**|**2022**
**£**
589
**589**
2,420
1,542
319,255
**323,217**
1,225
**324,442**
325,031
**325,031**
325,031
**325,031**|**2021**
**£**
589| |---|---|---| |||**589**
2,420
1,436
314,647| |||**318,503**
(1,120)| |||**317,383**| |||317,972| |||**317,972**| |||317,972| |||**317,972**| For the year ended 30 November 2022 the company was entitled to exemption from audit under section 477 of the companies act 2006 relating to small companies. Directors' responsibilities: 1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. 2. The directors acknowledge their responsibilities for complying with the requirements of the companies act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime of Part 15 of the Companies Act 2006. 8 of 15 FIBROMYALGIA ACTION UK Statement of Financial Position As at 30 November 2022 The financial statements were approved by the board of directors on 26 January 2023 and were signed on its behalf by: -------------------------------- Glen McGregor Director 9 of 15 FIBROMYALGIA ACTION UK Notes to the Financial Statements For the year ended 30 November 2022 ## **General Information** Fibromyalgia Action UK is a private company, limited by shares, registered in Scotland, registration number SC492045, registration address 12 Seedhill Road, 3007 Mile End Mill, Paisley, PA1 1JS. The presentation currency is £ sterling. ## **1. Accounting policies** ## **Significant accounting policies** ## **Statement of compliance** These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. ## **Basis of preparation** The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. ## **Group accounts** The company is a parent company subject to the small companies regime. The company and its subsidiary comprise a small group. The company has, therefore, taken advantage of the option provided by section 398 of the Companies Act 2006 not to prepare group accounts. ## **Turnover** Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. ## **Government grants** Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred. ## **Operating lease rentals** Rentals payable under operating leases are charged against income on a straight line basis over the lease term. ## **Research and development expenditure** Research and development expenditure is charged to the income statement in the period in which it is incurred. ## **Foreign currencies** Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement. 10 of 15 FIBROMYALGIA ACTION UK Notes to the Financial Statements For the year ended 30 November 2022 ## **Preference dividends** Where preference shares are classed as liabilities rather than equity any preference dividends paid are included in interest payable and similar charges within the income statement. ## **Tangible fixed assets** Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: Fixtures and Fittings 4 Straight Line ## **Stocks** Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. ## **2. Operating profit/(loss)** |**Operating profit/(loss)**||| |---|---|---| ||**2022**|**2021**| ||**£**|**£**| |The operating profit is stated after charging:||| |Operating leases|2|860| ## **3. Average number of employees** Average number of employees during the year was 4 (2021 : 4). ## **4. Interest payable and similar charges** |Bank & Other Loan Interest|**2022**
**£**
0
**0**|**2021**
**£**
16| |---|---|---| |||**16**| 11 of 15 ## FIBROMYALGIA ACTION UK Notes to the Financial Statements For the year ended 30 November 2022 |**5. Tangible fixed assets**
**Cost or valuation**
At 01 December 2021
Additions
Disposals
At 30 November 2022
**Depreciation**
At 01 December 2021
Charge for year
On disposals
At 30 November 2022
**Net book values**
Closing balance as at 30 November 2022
Opening balance as at 01 December 2021
**6. Stocks**
Stocks
**7. Debtors: amounts falling due within one year**
Trade Debtors
Prepayments & Accrued Income||Fixtures
and Fittings
**£**
5,215
-
-
**5,215**
4,626
-
-
**4,626**
**589**
**589**
**2022**
**£**
2,420
**2,420**
**2022**
**£**
294
1,248
**1,542**|**Total**
**£**
5,215
-
-| |---|---|---|---| ||||**5,215**| ||||4,626
-
-| ||||**4,626**| ||||**589**| ||||**589**| ||||**2021**
**£**
2,420
**2,420**
**2021**
**£**
294
1,142
**1,436**| 12 of 15 ## FIBROMYALGIA ACTION UK Notes to the Financial Statements For the year ended 30 November 2022 ## **8. Creditors: amount falling due within one year** |**Creditors: amount falling due within one year**||| |---|---|---| |Trade Creditors
Accrued Expenses
Other Creditors|**2022**
**£**
1,078
252
(2,555)
**(1,225)**|**2021**
**£**
927
194
(1)| |||**1,120**| ## **9. Profit and loss account** |**Profit and loss account**|| |---|---| |Balance at 01 December 2021
Profit for the year
Balance at 30 November 2022|**2022**
**£**
317,972
7,059| ||**325,031**| 13 of 15 ## FIBROMYALGIA ACTION UK Detailed Income Statement For the year ended 30 November 2022 |**Turnover**
Sales
Bank Interest
Donations Recieved
Payroll Income
Charities Aid Foundation
Legacies
Other Income
**Cost of sales**
Purchases
Direct Wages & Salaries
Employer's PAYE & NI Contributions
Pension Contributions
Other Direct Costs
Gross profit
**Selling and distribution costs**
Transport, Freight & Carriage
Operating Lease Charges - Plant & Equipment
**Administrative expenses**
Wages & Salaries
Employer's PAYE & NI Contributions
Pension Contributions
Staff Training
Staff Welfare
Accountancy Fees
Legal and Professional Fees (Allowable)
Rates & Water
Rent
Light, Heat & Power
Cleaning of Premises
General Travel Expenses
Bad Debts Written Off (Specific)|4,288
38,311
2,986
1,264
1,717|**2022**
**£**
34
7
75,821
1,269
522
194
25,393
**103,240**





(48,566)
**54,674**


(3,577)












|







930
41,180
0
0
1,289|**2021**
**£**
0
0
77,184
7,472
1,164
34,310
34,944| |---|---|---|---|---| |||||**155,074**
(43,399)| ||3,575
2||
2,913
860|| |||||**111,675**
(3,773)| ||796
0
0
173
43
530
1,375
2,558
21,749
1,936
30
0
0||13,941
4,861
1,867
0
279
660
2,121
0
23,352
1,047
0
845
4,380|| 14 of 15 ## FIBROMYALGIA ACTION UK Detailed Income Statement For the year ended 30 November 2022 |Bank Charges
Exchange Rate Losses/Gains
Advertising
General Insurance
Computer Expenses
Stationery & Postage
Telephone, Fax & Internet
Sundry Expenses
Trustees Expenses
Subscriptions
Volunteer expenses
Operating profit
**Interest payable and similar charges**
Bank & Other Loan Interest
**Profit/(Loss) on ordinary activities before**
**taxation**
**Profit/(Loss) for the financial year**|163
144
0
3,486
2,591
2,449
1,646
625
140
3,252
352|










(44,038)
**7,059**

0
**7,059**
**7,059**|222
102
1,238
2,358
10,953
3,677
1,938
211
1,226
2,619
1,992|(79,889)| |---|---|---|---|---| ||0||
16|| |||||**28,013**
(16)| |||||| |||||**27,997**| |||||**27,997**| 15 of 15